Pulse - Lower clot risk with levonorgestrel
Links shared publicly online about this topic.
- 318total visits
Pulse - Lower clot risk with levonorgestrel
View full resource at pulsetoday.co.uk
Tags: Sex and Intimacy, Second-Generation Progestin, Progestin in Birth Control Pills, Levonorgestrel
Most Recently Shared on May 4, 2011 at 2:10 pm By:
Lower clot risk with levonorgestrel: Two new studies have added to evidence that some types of contraceptive pil... http://bit.ly/mjqZbW
Higher blood clot risk for newer contraceptive pill - News - Virtual Medical Centre
virtualmedicalcentre.com — “UK women currently using the drospirenone pill were about three times more likely to develop non-fatal venous thromboembolism than similar women taking levonorgestrel formulations.” View full resource at virtualmedicalcentre.com
Most Recently Shared on May 13, 2011 at 2:10 pm By:
Higher blood clot risk for newer contraceptive pill http://dlvr.it/RbPGL #Healthnews
Bayer's birth control pills may increase risk of venous thromboembolism
news-medical.net — “The following release is being issued by law firms RodaNast, P.C.; Levin, Fishbein, Sedran & Berman and Feldman & Pinto: According to two new studies published in the online edition of the British Medical Journal, Bayer's birth control pills Yaz and Yasmin, containing a new progestin drospirenone, carry up to triple the risk of serious blood clots over traditional pills containing the progestin levonorgestrel.” View full resource at news-medical.net
Most Recently Shared on April 25, 2011 at 4:10 am By:
Bayer's birth control pills may increase risk of venous thromboembolism: The following release is being issued b... http://bit.ly/gs9pS6
Medical News: Fourth Generation Progestin Increases Risk of Clots - in Cardiovascular, Venous Thrombosis from MedPage Today
medpagetoday.com — “Women using oral contraceptives that contain the progestin drospirenone (Yaz, Yasmin) have approximately twice the risk of nonfatal venous thromboembolism as those using levonorgestrel contraceptives,” View full resource at medpagetoday.com
Most Recently Shared on April 23, 2011 at 9:00 pm By:
Fourth Generation Progestin Increases Risk of Clots - this progestin is used by many women with PCOS. http://ow.ly/4FB61
Newer contraceptives increase risk of blood clot, 2 studies find - Related Stories - ANA SmartBrief
smartbrief.com — “Women using Bayer's Yasmin and other oral contraceptives containing drospirenone have as much as threefold greater risk of venous thromboembolism compared with users of pills that contain levonorgestrel, an older synthetic hormone, according to two studies published in the British Medical Journal. --” View full resource at smartbrief.com
Most Recently Shared on April 22, 2011 at 7:59 pm By:
Newer contraceptives increase risk of blood clot, 2 studies find http://sbne.ws/r/7kb2
Contraception drospirenone raises risk for blood clots
news-medical.net — “Two new drug safety studies conducted by researchers at Boston University School of Medicine (BUSM) provide strong evidence that women taking oral contraception with drospirenone have an increased risk of nonfatal venous thromboembolism, or blood clots, compared to women taking oral contraception with levonorgestrel.” View full resource at news-medical.net
Most Recently Shared on April 22, 2011 at 1:03 am By:
Pregnancy News: Contraception drospirenone raises risk for blood clots: Two new drug safety studies conducted by... http://bit.ly/enLLxL
Pill choice affects clot risk | NHS Choices | Nursing Times
nursingtimes.net — “'Women are not routinely using the safest brand of contraceptive pill', reported The Guardian. The newspaper said that all types of combined contraceptive pill carry a risk of blood clots, but some have a higher risk than others. It said that researchers have found that the safest pillshadcombined low-dose oestrogen and levonorgestrel.” View full resource at nursingtimes.net
Most Recently Shared on August 19, 2009 at 11:26 am By:
Behind the Headlines Pill choice affects clot risk : ‘Women are not routinely using the safe.. http://bit.ly/SrxWI
Advertisement

